Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients in oncology, neurosciences, rare diseases, immunology, infectious diseases, hematology, hemophilia, and respiratory diseases. We combine cutting-edge research at Roche, Genentech in the U.S., Chugai in Japan and over 150 partners worldwide with strength in clinical development, manufacturing and commercial operations. We look for first-in-class or best-in-class opportunities that address diseases of unmet medical need and have the potential to revolutionize the standard of care. Thanks to our Pharmaceuticals Division’s broad-based portfolio, we are one of the world’s leading providers of clinically differentiated medicines.
Roche Pharmaceuticals is living proof that scientific invention leads to products that truly improve patients’ lives. Our inspiring tradition of excellence in science dates back more than a century. Today, as then, our strategy is rooted in fostering excellence in science and empowering scientists to create breakthroughs in life science that will make a difference tomorrow.